Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPT-C for PTSD and OUD in Veterans on Buprenorphine
NCT03605342Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2018
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in post-traumatic stress disorder (PTSD) and opioid use disorder (OUD) (2 arms), sponsored by VA Office of Research & Development. Primary endpoints: Clinician Administered PTSD Scale at Week 12 and PTSD Checklist - Military Version at Week 12. Started Oct 2018; status: terminated.
02
Conditions
post-traumatic stress disorder (PTSD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03605342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03605342.